Tumor cell death after electrotransfer of plasmid DNA is associated with cytosolic DNA sensor upregulation
Tumor cell death after electrotransfer of plasmid DNA is associated with cytosolic DNA sensor upregulation |
https://doi.org/10.18632/oncotarget.24816
Katarina Znidar,
Masa Bosnjak,
Nina Semenova,
Olga Pakhomova,
Loree Heller,
and Maja Cemazar
|
18665-18681 |
Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice
Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice |
https://doi.org/10.18632/oncotarget.24588
Lorena Simón-Gracia,
Pablo Scodeller,
Sergio Salazar Fuentes,
Vanessa Gómez Vallejo,
Xabier Ríos,
Eneko San Sebastián,
Valeria Sidorenko,
Desirè Di Silvio,
Meina Suck,
Federica De Lorenzi,
Larissa Yokota Rizzo,
Saskia von Stillfried,
Kalle Kilk,
Twan Lammers,
Sergio E. Moya,
and Tambet Teesalu
|
18682-18697 |
Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer |
https://doi.org/10.18632/oncotarget.24617
Akira Okita,
Shin Takahashi,
Kota Ouchi,
Masahiro Inoue,
Mika Watanabe,
Mareyuki Endo,
Hiroshi Honda,
Yasuhide Yamada,
and Chikashi Ishioka
|
18698-18711 |
Comprehensive analysis of telomerase inhibition by gallotannin
Comprehensive analysis of telomerase inhibition by gallotannin |
https://doi.org/10.18632/oncotarget.24642
Nikita Savelyev,
Polina Baykuzina,
Svetlana Dokudovskaya,
Olga Lavrik,
Maria Rubtsova,
and Olga Dontsova
|
18712-18719 |
Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas |
https://doi.org/10.18632/oncotarget.24643
Xiujuan Li,
Kailash Singh,
Zhengkang Luo,
Mariela Mejia-Cordova,
Maria Jamalpour,
Björn Lindahl,
Ganlin Zhang,
Stellan Sandler,
and Michael Welsh
|
18720-18733 |
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC |
https://doi.org/10.18632/oncotarget.24648
Toni Jauset,
Daniel Massó-Vallés,
Sandra Martínez-Martín,
Marie-Eve Beaulieu,
Laia Foradada,
Francesco Paolo Fiorentino,
Jun Yokota,
Bernard Haendler,
Stephan Siegel,
Jonathan R. Whitfield,
and Laura Soucek
|
18734-18746 |
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma in vitro
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma in vitro |
https://doi.org/10.18632/oncotarget.24650
Tobias Engl,
Jochen Rutz,
Sebastian Maxeiner,
Sorel Fanguen,
Eva Juengel,
Sebastian Koschade,
Frederik Roos,
Wael Khoder,
Igor Tsaur,
and Roman A. Blaheta
|
18747-18759 |
Synapsin I and Synapsin II regulate neurogenesis in the dentate gyrus of adult mice
Synapsin I and Synapsin II regulate neurogenesis in the dentate gyrus of adult mice |
https://doi.org/10.18632/oncotarget.24655
Raffaella Barbieri,
Andrea Contestabile,
Maria Grazia Ciardo,
Nicola Forte,
Antonella Marte,
Pietro Baldelli,
Fabio Benfenati,
and Franco Onofri
|
18760-18774 |
Integrated multigene expression panel to prognosticate patients with gastric cancer
Integrated multigene expression panel to prognosticate patients with gastric cancer |
https://doi.org/10.18632/oncotarget.24661
Mitsuro Kanda,
Kenta Murotani,
Haruyoshi Tanaka,
Takashi Miwa,
Shinichi Umeda,
Chie Tanaka,
Daisuke Kobayashi,
Masamichi Hayashi,
Norifumi Hattori,
Masaya Suenaga,
Suguru Yamada,
Goro Nakayama,
Michitaka Fujiwara,
and Yasuhiro Kodera
|
18775-18785 |
Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy
Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy |
https://doi.org/10.18632/oncotarget.24666
Malin Kaliff,
Bengt Sorbe,
Louise Bohr Mordhorst,
Gisela Helenius,
Mats G. Karlsson,
and Gabriella Lillsunde-Larsson
|
18786-18796 |
Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis
Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis |
https://doi.org/10.18632/oncotarget.24694
Hanan Goldberg,
Zachary Klaassen,
Thenappan Chandrasekar,
Rashid Sayyid,
Girish S. Kulkarni,
Robert J. Hamilton,
and Neil E. Fleshner
|
18797-18810 |
A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11
A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11 |
https://doi.org/10.18632/oncotarget.24702
Hironaga Satake,
Yu Sunakawa,
Yuji Miyamoto,
Masato Nakamura,
Hiroshi Nakayama,
Manabu Shiozawa,
Akitaka Makiyama,
Kazuma Kobayashi,
Yutaro Kubota,
Misuzu Mori,
Masahito Kotaka,
Akinori Takagane,
Masahiro Gotoh,
Masahiro Takeuchi,
Masashi Fujii,
Wararu Ichikawa,
and Takashi Sekikawa
|
18811-18820 |
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10 |
https://doi.org/10.18632/oncotarget.24568
Kaku Goto,
Jun Arai,
Anthony Stephanou,
and Naoya Kato
|
18821-18831 |
Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system
Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system |
https://doi.org/10.18632/oncotarget.24777
Olimpia Alessandra Buoninfante,
Bas Pilzecker,
Muhammad Assad Aslam,
Ioannis Zavrakidis,
Rianne van der Wiel,
Marieke van de Ven,
Paul C.M. van den Berk,
and Heinz Jacobs
|
18832-18843 |
Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment
Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment |
https://doi.org/10.18632/oncotarget.24787
Florian Lüke,
Raquel Blazquez,
Rezan Fahrioglu Yamaci,
Xin Lu,
Benedikt Pregler,
Stefan Hannus,
Karin Menhart,
Dirk Hellwig,
Hans-Jürgen Wester,
Saskia Kropf,
Daniel Heudobler,
Jirka Grosse,
Jutta Moosbauer,
Markus Hutterer,
Peter Hau,
Markus J. Riemenschneider,
Michaela Bayerlová,
Annalen Bleckmann,
Bernhard Polzer,
Tim Beißbarth,
Christoph A. Klein,
and Tobias Pukrop
|
18844-18857 |
Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours
Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours |
https://doi.org/10.18632/oncotarget.24789
Ben Babourina-Brooks,
Sarah Kohe,
Simrandip K. Gill,
Lesley MacPherson,
Martin Wilson,
Nigel P. Davies,
and Andrew C. Peet
|
18858-18868 |
Recruitment of mitofusin 2 into “lipid rafts” drives mitochondria fusion induced by Mdivi-1
Recruitment of mitofusin 2 into “lipid rafts” drives mitochondria fusion induced by Mdivi-1 |
https://doi.org/10.18632/oncotarget.24792
Laura Ciarlo,
Rosa Vona,
Valeria Manganelli,
Lucrezia Gambardella,
Carla Raggi,
Matteo Marconi,
Walter Malorni,
Maurizio Sorice,
Tina Garofalo,
and Paola Matarrese
|
18869-18884 |
Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET
Differentiation-inducing therapeutic effect of Notch inhibition in reversing malignant transformation of liver normal stem cells via MET |
https://doi.org/10.18632/oncotarget.24421
Hao Luo,
Wei-Hui Liu,
Hong-Yin Liang,
Hong-Tao Yan,
Ning Lin,
Dong-Yu Li,
Tao Wang,
and Li-Jun Tang
|
18885-18895 |
DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells
DNMT1 ablation suppresses tumorigenesis by inhibiting the self-renewal of esophageal cancer stem cells |
https://doi.org/10.18632/oncotarget.24116
Ying Teng,
Xiying Yu,
Hui Yuan,
Liping Guo,
Wei Jiang,
and Shih-Hsin Lu
|
18896-18907 |
Assessment of the Palliative Prognostic Index in hospitalized oncologic patients treated by a palliative care team: impact of acute concomitant diseases
Assessment of the Palliative Prognostic Index in hospitalized oncologic patients treated by a palliative care team: impact of acute concomitant diseases |
https://doi.org/10.18632/oncotarget.24826
Carmen Palomar-Muñoz,
Marina Martín-Zamorano,
Amparo Mogollo,
Susana Pascual-Pérez,
Inmaculada Rodríguez-Morales,
and José-Antonio Girón-González
|
18908-18915 |
Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy
Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy |
https://doi.org/10.18632/oncotarget.24828
Elenaé Vázquez-Ulloa,
Ana Clara Ramos-Cruz,
Diddier Prada,
Alejandro Avilés-Salas,
Alma Delia Chávez-Blanco,
Luis A. Herrera,
Marcela Lizano,
and Adriana Contreras-Paredes
|
18916-18928 |
Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine
Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine |
https://doi.org/10.18632/oncotarget.24838
Vincenzo Grassia,
Angela Lombardi,
Hiromichi Kawasaki,
Carmela Ferri,
Letizia Perillo,
Laura Mosca,
Donatella Delle Cave,
Ludovica Nucci,
Marina Porcelli,
and Michele Caraglia
|
18929-18938 |
Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease
Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease |
https://doi.org/10.18632/oncotarget.24851
Ying-Hsien Huang,
Mao-Hung Lo,
Xin-Yuan Cai,
and Ho-Chang Kuo
|
18939-18948 |
The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition
The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition |
https://doi.org/10.18632/oncotarget.24855
Po-Lin Tseng,
Chih-Wei Chen,
Keng-Hsun Hu,
Hung-Chi Cheng,
Yuan-Ho Lin,
Wen-Hui Tsai,
Tain-Junn Cheng,
Wei-Hsuan Wu,
Chin-Wei Yeh,
Chin-Chih Lin,
Hui-Ju Tsai,
Hao-Chun Chang,
Jiin-Haur Chuang,
Yan-Shen Shan,
and Wen-Tsan Chang
|
18949-18969 |
Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma
Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.24863
Marie Shimanuki,
Yorihisa Imanishi,
Yoichiro Sato,
Nana Nakahara,
Daisuke Totsuka,
Emiri Sato,
Sena Iguchi,
Yasuo Sato,
Keiko Soma,
Yasutomo Araki,
Seiji Shigetomi,
Satoko Yoshida,
Kosuke Uno,
Yusuke Ogawa,
Takehiro Tominaga,
Yuichi Ikari,
Junko Nagayama,
Ayako Endo,
Koshiro Miura,
Takuya Tomioka,
Hiroyuki Ozawa,
and Kaoru Ogawa
|
18970-18984 |
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer |
https://doi.org/10.18632/oncotarget.24867
Cesar August Santa-Maria,
Taigo Kato,
Jae-Hyun Park,
Kazuma Kiyotani,
Alfred Rademaker,
Ami N. Shah,
Leeaht Gross,
Luis Z. Blanco,
Sarika Jain,
Lisa Flaum,
Claudia Tellez,
Regina Stein,
Regina Uthe,
William J. Gradishar,
Massimo Cristofanilli,
Yusuke Nakamura,
and Francis J. Giles
|
18985-18996 |
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma |
https://doi.org/10.18632/oncotarget.24871
Valentina Audrito,
Antonella Managò,
Federica Zamporlini,
Eliana Rulli,
Federica Gaudino,
Gabriele Madonna,
Stefania D'Atri,
Gian Carlo Antonini Cappellini,
Paolo Antonio Ascierto,
Daniela Massi,
Nadia Raffaelli,
Mario Mandalà,
and Silvia Deaglio
|
18997-19005 |
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden |
https://doi.org/10.18632/oncotarget.24873
Adam E. Frampton,
Mireia Mato Prado,
,
Ana Belen Fajardo-Puerta,
Zaynab A.R. Jawad,
Phillip Lawton,
Elisa Giovannetti,
Nagy A. Habib,
Leandro Castellano,
Justin Stebbing,
Jonathan Krell,
and Long R. Jiao
|
19006-19013 |
miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children
miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children |
https://doi.org/10.18632/oncotarget.24874
Sara Stigliani,
Fabio Morandi,
Luca Persico,
Corrado Lagazio,
Giovanni Erminio,
Paola Scaruffi,
and Maria Valeria Corrias
|
19014-19025 |
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody |
https://doi.org/10.18632/oncotarget.24876
Tadanobu Nagaya,
Shuhei Okuyama,
Fusa Ogata,
Yasuhiro Maruoka,
Deborah W. Knapp,
Sophia N. Karagiannis,
Judit Fazekas-Singer,
Peter L. Choyke,
Amy K. LeBlanc,
Erika Jensen-Jarolim,
and Hisataka Kobayashi
|
19026-19038 |
Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes
Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes |
https://doi.org/10.18632/oncotarget.24886
Raphael Hohlfeld,
Sabine Brandt,
Anja Bernhardt,
Xenia Gorny,
Daniel Schindele,
Burkhard Jandrig,
Martin Schostak,
Berend Isermann,
Jonathan A. Lindquist,
and Peter R. Mertens
|
19039-19049 |
Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer
Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer |
https://doi.org/10.18632/oncotarget.24887
Aida Barreiro-Alonso,
Mónica Lamas-Maceiras,
Rosa García-Díaz,
Esther Rodríguez-Belmonte,
Lu Yu,
Mercedes Pardo,
Jyoti S. Choudhary,
and María Esperanza Cerdán
|
19050-19064 |
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma
Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma |
https://doi.org/10.18632/oncotarget.24897
Yasuo Takashima,
Atsushi Kawaguchi,
Tomohiko Kanayama,
Azusa Hayano,
and Ryuya Yamanaka
|
19065-19078 |
An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy
An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy |
https://doi.org/10.18632/oncotarget.24901
Vanessa Szablewski,
Caroline Bret,
Alboukadel Kassambara,
Julie Devin,
Guillaume Cartron,
Valérie Costes-Martineau,
and Jérôme Moreaux
|
19079-19099 |
Myofibroblast androgen receptor expression determines cell survival in co-cultures of myofibroblasts and prostate cancer cells in vitro
Myofibroblast androgen receptor expression determines cell survival in co-cultures of myofibroblasts and prostate cancer cells in vitro |
https://doi.org/10.18632/oncotarget.24913
Helen M. Palethorpe,
Damien A. Leach,
Eleanor F. Need,
Paul A. Drew,
and Eric Smith
|
19100-19114 |
Total lesion glycolysis on FDG-PET/CT before salvage surgery predicts survival in laryngeal or pharyngeal cancer
Total lesion glycolysis on FDG-PET/CT before salvage surgery predicts survival in laryngeal or pharyngeal cancer |
https://doi.org/10.18632/oncotarget.24914
Hidenori Suzuki,
Tsuneo Tamaki,
Masami Nishio,
Yusuke Nakata,
Nobuhiro Hanai,
Daisuke Nishikawa,
Yusuke Koide,
and Yasuhisa Hasegawa
|
19115-19122 |
Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells
Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells |
https://doi.org/10.18632/oncotarget.24919
Shojiro Kitajima,
Kian Leong Lee,
Masaki Fujioka,
Wendi Sun,
Jia You,
Grace Sushin Chia,
Hideki Wanibuchi,
Shuhei Tomita,
Marito Araki,
Hiroyuki Kato,
and Lorenz Poellinger
|
19123-19135 |
Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease
Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease |
https://doi.org/10.18632/oncotarget.24927
Agnieszka Szymczyk,
Sylwia Chocholska,
Arkadiusz Macheta,
Dariusz Szczepanek,
Marek Hus,
and Monika Podhorecka
|
19136-19146 |
CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma
CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma |
https://doi.org/10.18632/oncotarget.24931
Nuray Erin,
Gamze Tanrıöver,
Anna Curry,
Muhlis Akman,
Özlem Duymuş,
and Reg Gorczynski
|
19147-19158 |
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells |
https://doi.org/10.18632/oncotarget.24937
Robert K. Nam,
Tania Benatar,
Yutaka Amemiya,
Christopher J.D. Wallis,
Joan Miguel Romero,
Melina Tsagaris,
Christopher Sherman,
Linda Sugar,
and Arun Seth
|
19159-19176 |
PD-L1 expression in medulloblastoma: an evaluation by subgroup
PD-L1 expression in medulloblastoma: an evaluation by subgroup |
https://doi.org/10.18632/oncotarget.24951
Allison M. Martin,
Christopher J. Nirschl,
Magda J. Polanczyk,
W. Robert Bell,
Thomas R. Nirschl,
Sarah Harris-Bookman,
Jillian Phallen,
Jessica Hicks,
Daniel Martinez,
Aleksandra Ogurtsova,
Haiying Xu,
Lisa M. Sullivan,
Alan K. Meeker,
Eric H. Raabe,
Kenneth J. Cohen,
Charles G. Eberhart,
Peter C. Burger,
Mariarita Santi,
Janis M. Taube,
Drew M. Pardoll,
Charles G. Drake,
and Michael Lim
|
19177-19191 |
Impact of pigment epithelium-derived factor on colorectal cancer in vitro and in vivo
Impact of pigment epithelium-derived factor on colorectal cancer in vitro and in vivo |
https://doi.org/10.18632/oncotarget.24953
Rhiannon L. Harries,
Sioned Owen,
Fiona Ruge,
Meleri Morgan,
Jun Li,
Zhangtao Zhang,
Keith G. Harding,
Jared Torkington,
Wen G. Jiang,
and Jun Cai
|
19192-19202 |
Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma
Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma |
https://doi.org/10.18632/oncotarget.24969
Marta Brunetti,
Ludmila Gorunova,
Ben Davidson,
Sverre Heim,
Ioannis Panagopoulos,
and Francesca Micci
|
19203-19208 |
Myoferlin regulates epithelial cancer cell plasticity and migration through autocrine TGF-β1 signaling
Myoferlin regulates epithelial cancer cell plasticity and migration through autocrine TGF-β1 signaling |
https://doi.org/10.18632/oncotarget.24971
Victoria R. Barnhouse,
Jessica L. Weist,
Vasudha C. Shukla,
Samir N. Ghadiali,
Douglas A. Kniss,
and Jennifer L. Leight
|
19209-19222 |
Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer
Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer |
https://doi.org/10.18632/oncotarget.24973
Shahrooz Rabizadeh,
Chad Garner,
John Zachary Sanborn,
Stephen C. Benz,
Sandeep Reddy,
and Patrick Soon-Shiong
|
19223-19232 |
Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia
Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia |
https://doi.org/10.18632/oncotarget.24976
Milan Škorvaga,
Matúš Durdík,
Pavol Košík,
Eva Marková,
Marek Holop,
Miroslav Kubeš,
Judita Puškáčová,
Alexandra Kolenová,
and Igor Belyaev
|
19233-19244 |
Global burden of neuroendocrine tumors and changing incidence in Kentucky
Global burden of neuroendocrine tumors and changing incidence in Kentucky |
https://doi.org/10.18632/oncotarget.24983
Aman Chauhan,
Qian Yu,
Neha Ray,
Zainab Farooqui,
Bin Huang,
Eric B. Durbin,
Thomas Tucker,
Mark Evers,
Susanne Arnold,
and Lowell B. Anthony
|
19245-19254 |
Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology
Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology |
https://doi.org/10.18632/oncotarget.24995
Emilia Vuttariello,
Elio Biffali,
Raimondo Pannone,
Anna Capiluongo,
Mario Monaco,
Valentina Sica,
Concetta Aiello,
Marco Matuozzo,
Maria Grazia Chiofalo,
Gerardo Botti,
and Gennaro Chiappetta
|
19255-19262 |
Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model |
https://doi.org/10.18632/oncotarget.24996
Kentaro Igarashi,
Kei Kawaguchi,
Shukuan Li,
Qinghong Han,
Yuying Tan,
Emily Gainor,
Tasuku Kiyuna,
Kentaro Miyake,
Masuyo Miyake,
Takashi Higuchi,
Hiromichi Oshiro,
Arun S. Singh,
Mark A. Eckardt,
Scott D. Nelson,
Tara A. Russell,
Sarah M. Dry,
Yunfeng Li,
Norio Yamamoto,
Katsuhiro Hayashi,
Hiroaki Kimura,
Shinji Miwa,
Hiroyuki Tsuchiya,
Fritz C. Eilber,
and Robert M. Hoffman
|
19263-19272 |
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells |
https://doi.org/10.18632/oncotarget.25018
Vincenza Ciaramella,
Carminia Maria Della Corte,
Concetta Di Mauro,
Stefano Tomassi,
Salvatore Di Maro,
Teresa Troiani,
Erika Martinelli,
Roberto Bianco,
Sandro Cosconati,
Riccardo Pierantoni,
Rosaria Meccariello,
Rosanna Chianese,
Fortunato Ciardiello,
and Floriana Morgillo
|
19273-19282 |
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients |
https://doi.org/10.18632/oncotarget.25019
Afroditi Nanou,
Frank A.W. Coumans,
Guus van Dalum,
Leonie L. Zeune,
David Dolling,
Wendy Onstenk,
Mateus Crespo,
Mariane Sousa Fontes,
Pasquale Rescigno,
Gemma Fowler,
Penny Flohr,
Christoph Brune,
Stefan Sleijfer,
Johann S. de Bono,
and Leon W.M.M. Terstappen
|
19283-19293 |
Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer
Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer |
https://doi.org/10.18632/oncotarget.25022
Amit Katz,
Uri Barash,
Ilanit Boyango,
Sari Feld,
Yaniv Zohar,
Edward Hammond,
Neta Ilan,
Ran Kremer,
and Israel Vlodavsky
|
19294-19306 |
Comparison and evaluation of two RGD peptides labelled with 68Ga or 18F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinoma
Comparison and evaluation of two RGD peptides labelled with 68Ga or 18F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinoma |
https://doi.org/10.18632/oncotarget.25028
Claire Provost,
Aurélie Prignon,
Laura Rozenblum-Beddok,
Quentin Bruyer,
Sylvie Dumont,
Fatiha Merabtene,
Valérie Nataf,
Cédric Bouteiller,
and Jean-Noël Talbot
|
19307-19316 |
Treosulfan induces distinctive gonadal toxicity compared with busulfan
Treosulfan induces distinctive gonadal toxicity compared with busulfan |
https://doi.org/10.18632/oncotarget.25029
Mattan Levi,
Salomon M. Stemmer,
Jerry Stein,
Ruth Shalgi,
and Irit Ben-Aharon
|
19317-19327 |
Stress and stem cells: adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells
Stress and stem cells: adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells |
https://doi.org/10.18632/oncotarget.25039
Nicola Alessio,
Tiziana Squillaro,
Servet Özcan,
Giovanni Di Bernardo,
Massimo Venditti,
Mariarosa Melone,
Gianfranco Peluso,
and Umberto Galderisi
|
19328-19341 |
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine |
https://doi.org/10.18632/oncotarget.25046
Marta Cabezón,
Joan Bargay,
Blanca Xicoy,
Olga García,
Josep Borrás,
Mar Tormo,
Sílvia Marcé,
Carme Pedro,
David Valcárcel,
Maria-José Jiménez,
Ramón Guàrdia,
Laura Palomo,
Salut Brunet,
Ferran Vall-Llovera,
Antoni Garcia,
Evarist Feliu,
and Lurdes Zamora On Behalf of the CETLAM Group
|
19342-19355 |
Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer
Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.25049
Michela Terlizzi,
Chiara Colarusso,
Ilaria De Rosa,
Nicolina De Rosa,
Pasquale Somma,
Carlo Curcio,
Alessandro Sanduzzi,
Pietro Micheli,
Antonio Molino,
Antonello Saccomanno,
Rosario Salvi,
Rita P. Aquino,
Aldo Pinto,
and Rosalinda Sorrentino
|
19356-19367 |
Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients |
https://doi.org/10.18632/oncotarget.25053
Shun-Ichiro Kageyama,
Keiji Nihei,
Katsuyuki Karasawa,
Takeshi Sawada,
Fumiaki Koizumi,
Shigeo Yamaguchi,
Shunsuke Kato,
Hidehiro Hojo,
Atsuhi Motegi,
Katsuya Tsuchihara,
and Tetsuo Akimoto
|
19368-19378 |
Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma
Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma |
https://doi.org/10.18632/oncotarget.25056
Cynthia De Carvalho Fischer,
Yue Hu,
Michael Morreale,
Wan Ying Lin,
Akhil Wali,
Maya Thakar,
Enusha Karunasena,
Rupashree Sen,
Yi Cai,
Lauren Murphy,
Cynthia A. Zahnow,
Harold Keer,
Manjusha Thakar,
and Nita Ahuja
|
19379-19395 |
Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years
Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years |
https://doi.org/10.18632/oncotarget.25036
Bradley R. Hall,
Andrew Cannon,
Pranita Atri,
Christopher S. Wichman,
Lynette M. Smith,
Apar K. Ganti,
Chandrakanth Are,
Aaron R. Sasson,
Sushil Kumar,
and Surinder K. Batra
|
19396-19405 |
Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment
Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment |
https://doi.org/10.18632/oncotarget.24779
Katsunori Tatsugami,
Mototsugu Oya,
Koki Kabu,
and Hideyuki Akaza
|
19406-19414 |
Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review |
https://doi.org/10.18632/oncotarget.24767
Monica Salerno,
Orazio Cascio,
Giuseppe Bertozzi,
Francesco Sessa,
Antonietta Messina,
Vincenzo Monda,
Luigi Cipolloni,
Antonio Biondi,
Aurora Daniele,
and Cristoforo Pomara
|
19415-19426 |
Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology |
https://doi.org/10.18632/oncotarget.24827
Magdalena Cisło,
Agata Anna Filip,
George Johan Arnold Offerhaus,
Bogumiła Ciseł,
Karol Rawicz-Pruszyński,
Małgorzata Skierucha,
and Wojciech Piotr Polkowski
|
19427-19442 |
Epigenetic regulation of long non-coding RNAs in gastric cancer
Epigenetic regulation of long non-coding RNAs in gastric cancer |
https://doi.org/10.18632/oncotarget.23821
Zhixia Zhou,
Zhijuan Lin,
Xin Pang,
Muhammad Akram Tariq,
Xiang Ao,
Peifeng Li,
and Jianxun Wang
|
19443-19458 |
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer |
https://doi.org/10.18632/oncotarget.25151
Rebecca C. Arend,
Angelina I. Londoño-Joshi,
Abhishek Gangrade,
Ashwini A. Katre,
Chandrika Kurpad,
Yonghe Li,
Rajeev S. Samant,
Pui-Kai Li,
Charles N. Landen,
Eddy S. Yang,
Bertha Hidalgo,
Ronald D. Alvarez,
John Michael Straughn,
Andres Forero,
and Donald J. Buchsbaum
|
19459-19459 |
Correction: Role of novel histone modifications in cancer
Correction: Role of novel histone modifications in cancer |
https://doi.org/10.18632/oncotarget.25152
Muthu K. Shanmugam,
Frank Arfuso,
Surendar Arumugam,
Arunachalam Chinnathambi,
Jinsong Bian,
Sudha Warrier,
Ling Zhi Wang,
Alan Prem Kumar,
Kwang Seok Ahn,
Gautam Sethi,
and Manikandan Lakshmanan
|
19460-19460 |